Russian Direct Investment Fund invests in Geropharm
The Russian Direct Investment Fund (RDIF) has made an investment in Geropharm, a Russian pharmaceutical company, specialising in restoring brain function and the treatment of diabetes. This investment utilises the mechanism designed to promote the development of companies with significant export potential. The proceeds will be used by Geropharm
